ArticleOncology letters2023
CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated.
Hyori Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papertrialcites it
ArticleOncology letters2023
Hyori Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.